BMY vs LGCY · P/E 17, rev $24.46B vs P/E 19, rev $64.2M
Bristol-Myers Squibb Company (BMY) versus Legacy Education Inc. (LGCY) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Legacy Education Inc. (LGCY) is a education & training services company listed on AMEX.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported LGCY revenue for 2025-06-30 was $64.2M. Net income was $7.5M. Revenue was up 39.5% from 2024-06-30 to 2025-06-30. LGCY currently screens at market cap $141.7M and trailing P/E 18.7.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. LGCY currently screens at market cap $141.7M and trailing P/E 18.7.
Not investment advice. Open the BMY and LGCY stock pages for the full models.
Not investment advice.